keyword
https://read.qxmd.com/read/26973742/managing-agitation-associated-with-schizophrenia-and-bipolar-disorder-in-the-emergency-setting
#101
REVIEW
Scott L Zeller, Leslie Citrome
INTRODUCTION: Patient agitation represents a significant challenge in the emergency department (ED), a setting in which medical staff are working under pressure dealing with a diverse range of medical emergencies. The potential for escalation into aggressive behavior, putting patients, staff, and others at risk, makes it imperative to address agitated behavior rapidly and efficiently. Time constraints and limited access to specialist psychiatric support have in the past led to the strategy of "restrain and sedate," which was believed to represent the optimal approach; however, it is increasingly recognized that more patient-centered approaches result in improved outcomes...
March 2016: Western Journal of Emergency Medicine
https://read.qxmd.com/read/26923996/-case-report-neuroleptic-malignant-syndrome-and-diagnostic-difficulties
#102
JOURNAL ARTICLE
C Khouri, S Planès, S Logerot, C Villier, M Mallaret
BACKGROUND: Neuroleptic malignant syndrome (NMS) is an uncommon but potentially fatal adverse effect of neuroleptic drugs. It is commonly characterized by muscular rigidity, fever, altered mental status, and autonomic dysfunction. Emerging of NMS is possible with all neuroleptics, classic and atypical. NMS occurs most often during the first week of treatment or after increasing the dosage of the neuroleptic medication. The frequency of NMS ranges from 0.07 to 2.2%. Its pathophysiology is not clearly understood but the blockade of dopamine receptors appears to be the central mechanism...
June 2016: L'Encéphale
https://read.qxmd.com/read/26797170/drugs-for-behavior-disorders-after-traumatic-brain-injury-systematic-review-and-expert-consensus-leading-to-french-recommendations-for-good-practice
#103
REVIEW
D Plantier, J Luauté
OBJECTIVE: There are no handbook or recommendations for the use of pharmacological agents to treat neurobehavioral disorders after traumatic brain injury (TBI). This work proposes a systematic review of the literature and a user guide on neuroleptics, antidepressants, beta-blockers, mood stabilizers and other medications for irritability, aggressiveness, agitation, impulsivity, depression, apathy… METHOD: Steering, working and reading groups (62 people) were formed under the control of the French High Authority for Health (HAS) in collaboration with the SOFMER scientific society (French Society of Physical and Rehabilitation Medicine)...
February 2016: Annals of Physical and Rehabilitation Medicine
https://read.qxmd.com/read/26714248/-parenteral-antipsychotics-in-the-treatment-of-agitation-and-aggression
#104
REVIEW
G Utzerath, D Reske, E Gouzoulis-Mayfrank
This overview presents the current scientific data on intramuscular administration of benperidole, aripiprazole, ziprasidone, and haloperidole and on inhaled loxapine with regard to their efficacy and tolerability as well as their pharmacodynamic and pharmacokinetic properties. In addition, the possible advantages and disadvantages of the different substances are compared when administered to patients who show tension, agitation and aggression.
December 2015: Fortschritte der Neurologie-Psychiatrie
https://read.qxmd.com/read/26687568/loxapine-for-reversal-of-antipsychotic-induced-metabolic-disturbances-a-chart-review
#105
JOURNAL ARTICLE
Seema Jain, Rebecca Andridge, Jessica A Hellings
Loxapine substitution is a promising option for patients with autism spectrum disorder (ASD) who develop antipsychotic-induced metabolic illness. We performed a chart review of 15 adolescents and adults meeting DSM-IV-TR criteria for ASD, all with antipsychotic-associated weight gain, who received low dose loxapine in an attempt to taper or discontinue the weight gain-associated antipsychotic. Mean weight loss was -5.7 kg, mean BMI reduction was -1.9, and mean triglyceride reduction was -33.7 mg/dl. At chart review, 14 of 15 subjects were rated 2 (Much Improved) or 1 (Very Much Improved) on the Clinical Global Impressions-Improvement scale (CGI-I)...
April 2016: Journal of Autism and Developmental Disorders
https://read.qxmd.com/read/26660169/quantitation-of-flecainide-mexiletine-propafenone-and-amiodarone-in-serum-or-plasma-using-liquid-chromatography-tandem-mass-spectrometry-lc-ms-ms
#106
JOURNAL ARTICLE
Matthew H Slawson, Kamisha L Johnson-Davis
Flecainide, mexiletine, propafenone, and amiodarone are antiarrhythmic drugs that are used primarily in the treatment of cardiac arrhythmias. The monitoring of the use of these drugs has applications in therapeutic drug monitoring and overdose situations. LC-MS/MS is used to analyze plasma/serum extracts with loxapine as the internal standard to ensure accurate quantitation and control for any potential matrix effects. Positive ion electrospray is used to introduce the analytes into the mass spectrometer. Selected reaction monitoring of two product ions for each analyte allows for the calculation of ion ratios which ensures correct identification of each analyte, while a matrix matched calibration curve is used for quantitation...
2016: Methods in Molecular Biology
https://read.qxmd.com/read/26597272/-inhaled-loxapine-for-emergency-treatment-of-agitated-patients-with-borderline-personality-disorder-a-series-of-five-cases
#107
JOURNAL ARTICLE
T H C Krüger, M A Wollmer, P Negt, H Frieling, S Jung, K G Kahl
No abstract text is available yet for this article.
November 2016: Der Nervenarzt
https://read.qxmd.com/read/26448403/inhaled-loxapine-for-acute-treatment-of-agitation-in-patients-with-borderline-personality-disorder-a-case-series
#108
LETTER
Kai G Kahl, Philip Negt, Axel Wollmer, Stefanie Jung, Tillmann H C Kruger
No abstract text is available yet for this article.
December 2015: Journal of Clinical Psychopharmacology
https://read.qxmd.com/read/26445139/a-randomized-placebo-controlled-repeat-dose-thorough-qt-study-of-inhaled-loxapine-in-healthy-volunteers
#109
JOURNAL ARTICLE
James V Cassella, Daniel A Spyker, Paul P Yeung
OBJECTIVE: This randomized, double-blind, active- and placebo-controlled, crossover, thorough QT study assessed the effect of two inhaled loxapine doses on cardiac repolarization as measured by corrected QT (QTc) interval in healthy subjects (ClinicalTrials.gov NCT01854710). METHODS: Subjects received two doses of inhaled loxapine (10 mg) 2 hours apart + oral placebo, two doses of inhaled placebo + oral placebo, or two doses of inhaled placebo + oral moxifloxacin (400 mg; positive control), with ≥ 3 days washout between treatments...
October 7, 2015: International Journal of Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/26439438/inhaled-loxapine-for-ect-pretreatment-for-agitation
#110
LETTER
Richard Jaffe, Michael Siniscalchi, Norma Cruz-Luna, Douglas Cosgrove
No abstract text is available yet for this article.
June 2016: Journal of ECT
https://read.qxmd.com/read/26398280/rhabdomyolysis-with-acute-renal-failure-and-deep-vein-thrombosis-induced-by-antipsychotic-drugs-a-case-report
#111
JOURNAL ARTICLE
I Jullian-Desayes, A Roselli, C Lamy, M C Alberto-Gondouin, N Janvier, G Venturi-Maestri
Atypical antipsychotics, the first line therapy for schizophrenia, have already been reported as causing rhabdomyolysis or isolated elevation in serum creatine kinase (SCK). This case report dealing with rhabdomyolysis in a 25-year-old man treated with antipsychotics is particularly unusual, due to the extremely high elevation in SCK and the ensuing acute renal failure. He was treated with loxapine 400 mg/day and risperidone 4 mg/day for 4 days and then loxapine was replaced by levomepromazine 300 mg/day...
November 2015: Pharmacopsychiatry
https://read.qxmd.com/read/25907529/alternate-routes-of-administration-of-antidepressant-and-antipsychotic-medications
#112
REVIEW
Bonnie M Kaminsky, Jolene R Bostwick, Sally K Guthrie
OBJECTIVE: To review the administration of antidepressant and antipsychotic medications via inhaled, intranasal, buccal, sublingual, transdermal, and rectal routes. DATA SOURCES: A PubMed search was conducted for all data through March 31, 2015 to identify pertinent literature. Search terms included the generic name of each antidepressant and antipsychotic medication in combination with the following terms: alternate routes of administration, inhaled, intranasal, buccal, sublingual, transdermal, and rectal...
July 2015: Annals of Pharmacotherapy
https://read.qxmd.com/read/25859275/revisiting-loxapine-a-systematic-review
#113
JOURNAL ARTICLE
Dina Popovic, Philippe Nuss, Eduard Vieta
Loxapine is an antipsychotic used in psychiatry for over 40 years with a well-established profile. Loxapine is a dibenzoxazepine tricyclic antipsychotic agent, available for oral, intramuscular and inhalatory administration. In the light of the recent approval by the regulatory agencies of inhaled loxapine for use in the acute treatment of mild-to-moderate agitation in adults affected with schizophrenia or bipolar disorder, this article aims to critically review the available literature on loxapine, irrespective of its formulation...
2015: Annals of General Psychiatry
https://read.qxmd.com/read/25819631/-carbamazepine-and-psychotropic-treatment-interaction-two-case-studies-of-carbamazepine-overdosage
#114
JOURNAL ARTICLE
A Fernandez, E Dor, M-L Menard, F Askenazy, S Thümmler
Drug interaction is a frequent situation in pediatrics and child psychiatry. Carbamazepine (CBZ) is an antiepileptic drug used as a mood stabilizer in child psychiatry. CBZ is known to be a potent inducer of various CYP isoenzymes of cytochrome P450, which might result in a decrease in the plasma concentration of associated treatments. We describe two cases of CBZ overdosage in adolescent inpatients (14 and 16 years). The patients were treated with risperidone associated with fluoxetine in one and with loxapine in the other case, and CBZ was introduced as a mood stabilizer...
May 2015: Archives de Pédiatrie: Organe Officiel de la Sociéte Française de Pédiatrie
https://read.qxmd.com/read/25808074/multiple-dose-pharmacokinetics-of-inhaled-loxapine-in-subjects-on-chronic-stable-antipsychotic-regimens
#115
RANDOMIZED CONTROLLED TRIAL
Daniel A Spyker, Robert A Riesenberg, James V Cassella
This randomized, double-blind, placebo-controlled, parallel-group study was to determine the pharmacokinetic characteristics, safety, and tolerability of multiple doses of inhaled loxapine aerosol in subjects on a stable, oral, chronic antipsychotic regimen. Loxapine was delivered by means of a unique thermally generated aerosol comprising drug particles of a size designed for deep lung delivery and absorption. Thirty-two subjects were randomized 1:1:1:1 to receive inhaled loxapine (total doses of 15, 20, or 30 mg) or inhaled placebo administered in 3 divided doses, given 4 hours apart...
September 2015: Journal of Clinical Pharmacology
https://read.qxmd.com/read/25782098/loxapine-add-on-for-adolescents-and-adults-with-autism-spectrum-disorders-and-irritability
#116
JOURNAL ARTICLE
Jessica A Hellings, Gregory Reed, Sharon E Cain, Xinghua Zhou, Francis X Barth, Michael G Aman, Gladys I Palaguachi, Dmytro Mikhnev, Rujia Teng, Rebecca Andridge, Marilyn Logan, Merlin G Butler, Joan C Han
OBJECTIVES: Our clinical experience with low dose loxapine (5-15 mg/day) suggests promising efficacy and safety for irritability in autism spectrum disorders (ASD). We studied low dose loxapine prospectively in adolescents and adults with ASD and irritability. Additionally, we measured loxapine and metabolite concentrations, and brain-derived neurotrophic factor (BDNF) as a biomarker of neuromodulation. METHODS: We performed a 12 week open trial of add-on loxapine in subjects, ages 13-65 years, diagnosed with ASD, and Aberrant Behavior Checklist-Irritability (ABC-I) subscale scores >14...
March 2015: Journal of Child and Adolescent Psychopharmacology
https://read.qxmd.com/read/25639013/-inhaled-loxapine-a-novel-treatment-for-agitation-in-psychotic-disorders
#117
REVIEW
Marcin Siwek
Psychomotor agitation is a widespread clinical problem both in patients with schizophrenia and BD. It is a highly hazardous condition, imposing significant risks in psychiatric emergency, as expressedby elevated ratios of adverse events and traumatic experiences (both for patients and medical staff). The available anti-agitation drugs have numerous disadvantages. The orally administered medications (even though preferable to:patients) take hours or even-days for the therapeutic effect to emerge .(and also there is a risk of exacerbating agitation in between)...
September 2014: Psychiatria Polska
https://read.qxmd.com/read/25609627/slack-channels-expressed-in-sensory-neurons-control-neuropathic-pain-in-mice
#118
JOURNAL ARTICLE
Ruirui Lu, Anne E Bausch, Wiebke Kallenborn-Gerhardt, Carsten Stoetzer, Natasja Debruin, Peter Ruth, Gerd Geisslinger, Andreas Leffler, Robert Lukowski, Achim Schmidtko
Slack (Slo2.2) is a sodium-activated potassium channel that regulates neuronal firing activities and patterns. Previous studies identified Slack in sensory neurons, but its contribution to acute and chronic pain in vivo remains elusive. Here we generated global and sensory neuron-specific Slack mutant mice and analyzed their behavior in various animal models of pain. Global ablation of Slack led to increased hypersensitivity in models of neuropathic pain, whereas the behavior in models of inflammatory and acute nociceptive pain was normal...
January 21, 2015: Journal of Neuroscience
https://read.qxmd.com/read/25592299/haloperidol-versus-first-generation-antipsychotics-for-the-treatment-of-schizophrenia-and-other-psychotic-disorders
#119
REVIEW
Markus Dold, Myrto T Samara, Chunbo Li, Magdolna Tardy, Stefan Leucht
BACKGROUND: Haloperidol is worldwide one of the most frequently used antipsychotic drugs with a very high market share. Previous narrative, unsystematic reviews found no differences in terms of efficacy between the various first-generation ("conventional", "typical") antipsychotic agents. This established the unproven psychopharmacological assumption of a comparable efficacy between the first-generation antipsychotic compounds codified in textbooks and treatment guidelines. Because this assumption contrasts with the clinical impression, a high-quality systematic review appeared highly necessary...
January 16, 2015: Cochrane Database of Systematic Reviews
https://read.qxmd.com/read/25365434/antipsychotic-drugs-and-safety-concerns-for-breast-feeding-infants
#120
REVIEW
Tapan Parikh, Dharmendra Goyal, Jonathan R Scarff, Steven Lippmann
Antipsychotic drugs prescribed to treat psychiatric symptoms during the postpartum period are secreted into breast milk. Because breast-feeding is crucial to infant development, it is important to select a medication that poses the fewest adverse consequences. Aripiprazole, haloperidol, perphenazine, and trifluoperazine demonstrate no known developmental dangers. Olanzapine, quetiapine, and risperidone are cited as safe, although monitoring is recommended. Chlorpromazine and clozapine may induce developmental concerns...
November 2014: Southern Medical Journal
keyword
keyword
6112
6
7
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.